nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—ABCB1—Levothyroxine—hypothyroidism	0.0996	0.28	CbGbCtD
Bromocriptine—ABCB1—Liothyronine—hypothyroidism	0.0996	0.28	CbGbCtD
Bromocriptine—ABCB1—Liotrix—hypothyroidism	0.0972	0.273	CbGbCtD
Bromocriptine—CYP3A4—Levothyroxine—hypothyroidism	0.0597	0.168	CbGbCtD
Bromocriptine—Cardiac failure congestive—Liothyronine—hypothyroidism	0.0126	0.0339	CcSEcCtD
Bromocriptine—Abdominal cramps—Dextrothyroxine—hypothyroidism	0.0114	0.0308	CcSEcCtD
Bromocriptine—Abdominal cramps—Levothyroxine—hypothyroidism	0.0114	0.0308	CcSEcCtD
Bromocriptine—HTR2A—cerebellar cortex—hypothyroidism	0.00963	0.059	CbGeAlD
Bromocriptine—DRD1—nerve—hypothyroidism	0.00906	0.0555	CbGeAlD
Bromocriptine—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00867	0.0233	CcSEcCtD
Bromocriptine—Myocardial infarction—Liothyronine—hypothyroidism	0.00863	0.0232	CcSEcCtD
Bromocriptine—Abdominal cramps—Liotrix—hypothyroidism	0.00842	0.0227	CcSEcCtD
Bromocriptine—Tingling sensation—Liotrix—hypothyroidism	0.00707	0.019	CcSEcCtD
Bromocriptine—Arrhythmia—Liothyronine—hypothyroidism	0.00706	0.019	CcSEcCtD
Bromocriptine—DRD4—heart—hypothyroidism	0.00668	0.041	CbGeAlD
Bromocriptine—CYP1A2—urine—hypothyroidism	0.00654	0.0401	CbGeAlD
Bromocriptine—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00618	0.0166	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00618	0.0166	CcSEcCtD
Bromocriptine—Hypertension—Liothyronine—hypothyroidism	0.00594	0.016	CcSEcCtD
Bromocriptine—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00575	0.0155	CcSEcCtD
Bromocriptine—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00575	0.0155	CcSEcCtD
Bromocriptine—HTR7—nerve—hypothyroidism	0.00566	0.0347	CbGeAlD
Bromocriptine—Tachycardia—Liothyronine—hypothyroidism	0.00548	0.0147	CcSEcCtD
Bromocriptine—DRD2—nerve—hypothyroidism	0.00535	0.0328	CbGeAlD
Bromocriptine—Hypotension—Liothyronine—hypothyroidism	0.00524	0.0141	CcSEcCtD
Bromocriptine—HTR2A—urine—hypothyroidism	0.00512	0.0314	CbGeAlD
Bromocriptine—Lightheadedness—Liotrix—hypothyroidism	0.00508	0.0137	CcSEcCtD
Bromocriptine—Dysphagia—Dextrothyroxine—hypothyroidism	0.00485	0.013	CcSEcCtD
Bromocriptine—Dysphagia—Levothyroxine—hypothyroidism	0.00485	0.013	CcSEcCtD
Bromocriptine—CYP3A4—urine—hypothyroidism	0.00474	0.029	CbGeAlD
Bromocriptine—Cardiac failure congestive—Liotrix—hypothyroidism	0.00455	0.0122	CcSEcCtD
Bromocriptine—Body temperature increased—Liothyronine—hypothyroidism	0.00444	0.0119	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00426	0.0115	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00426	0.0115	CcSEcCtD
Bromocriptine—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00424	0.0114	CcSEcCtD
Bromocriptine—Myocardial infarction—Levothyroxine—hypothyroidism	0.00424	0.0114	CcSEcCtD
Bromocriptine—Hypoglycaemia—Liotrix—hypothyroidism	0.00423	0.0114	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Liotrix—hypothyroidism	0.00421	0.0113	CcSEcCtD
Bromocriptine—DRD4—testis—hypothyroidism	0.00412	0.0253	CbGeAlD
Bromocriptine—Dysphagia—Liotrix—hypothyroidism	0.00356	0.00959	CcSEcCtD
Bromocriptine—HTR2A—nerve—hypothyroidism	0.00353	0.0216	CbGeAlD
Bromocriptine—Arrhythmia—Levothyroxine—hypothyroidism	0.00347	0.00933	CcSEcCtD
Bromocriptine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00347	0.00933	CcSEcCtD
Bromocriptine—Alopecia—Levothyroxine—hypothyroidism	0.00343	0.00922	CcSEcCtD
Bromocriptine—Alopecia—Dextrothyroxine—hypothyroidism	0.00343	0.00922	CcSEcCtD
Bromocriptine—Tension—Dextrothyroxine—hypothyroidism	0.00331	0.00892	CcSEcCtD
Bromocriptine—Tension—Levothyroxine—hypothyroidism	0.00331	0.00892	CcSEcCtD
Bromocriptine—Nervousness—Dextrothyroxine—hypothyroidism	0.00328	0.00883	CcSEcCtD
Bromocriptine—Nervousness—Levothyroxine—hypothyroidism	0.00328	0.00883	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Liotrix—hypothyroidism	0.00313	0.00843	CcSEcCtD
Bromocriptine—Myocardial infarction—Liotrix—hypothyroidism	0.00312	0.00838	CcSEcCtD
Bromocriptine—Agitation—Dextrothyroxine—hypothyroidism	0.0031	0.00835	CcSEcCtD
Bromocriptine—Agitation—Levothyroxine—hypothyroidism	0.0031	0.00835	CcSEcCtD
Bromocriptine—DRD5—female gonad—hypothyroidism	0.00306	0.0188	CbGeAlD
Bromocriptine—Convulsion—Levothyroxine—hypothyroidism	0.00293	0.00787	CcSEcCtD
Bromocriptine—Convulsion—Dextrothyroxine—hypothyroidism	0.00293	0.00787	CcSEcCtD
Bromocriptine—Anxiety—Levothyroxine—hypothyroidism	0.00286	0.00771	CcSEcCtD
Bromocriptine—Anxiety—Dextrothyroxine—hypothyroidism	0.00286	0.00771	CcSEcCtD
Bromocriptine—Hypoaesthesia—Liotrix—hypothyroidism	0.00284	0.00764	CcSEcCtD
Bromocriptine—Confusional state—Levothyroxine—hypothyroidism	0.00278	0.00748	CcSEcCtD
Bromocriptine—Confusional state—Dextrothyroxine—hypothyroidism	0.00278	0.00748	CcSEcCtD
Bromocriptine—Shock—Dextrothyroxine—hypothyroidism	0.00271	0.0073	CcSEcCtD
Bromocriptine—Shock—Levothyroxine—hypothyroidism	0.00271	0.0073	CcSEcCtD
Bromocriptine—Tachycardia—Levothyroxine—hypothyroidism	0.00269	0.00724	CcSEcCtD
Bromocriptine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00269	0.00724	CcSEcCtD
Bromocriptine—HTR1B—cardiovascular system—hypothyroidism	0.00257	0.0158	CbGeAlD
Bromocriptine—ADRB1—heart—hypothyroidism	0.00256	0.0157	CbGeAlD
Bromocriptine—Arrhythmia—Liotrix—hypothyroidism	0.00255	0.00686	CcSEcCtD
Bromocriptine—HTR2B—adrenal cortex—hypothyroidism	0.00254	0.0156	CbGeAlD
Bromocriptine—Alopecia—Liotrix—hypothyroidism	0.00252	0.00679	CcSEcCtD
Bromocriptine—Insomnia—Levothyroxine—hypothyroidism	0.00249	0.00671	CcSEcCtD
Bromocriptine—Insomnia—Dextrothyroxine—hypothyroidism	0.00249	0.00671	CcSEcCtD
Bromocriptine—HTR1D—cardiovascular system—hypothyroidism	0.00249	0.0153	CbGeAlD
Bromocriptine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00246	0.00661	CcSEcCtD
Bromocriptine—Dyspnoea—Levothyroxine—hypothyroidism	0.00246	0.00661	CcSEcCtD
Bromocriptine—HTR2B—heart—hypothyroidism	0.00245	0.015	CbGeAlD
Bromocriptine—Tension—Liotrix—hypothyroidism	0.00244	0.00656	CcSEcCtD
Bromocriptine—Dysgeusia—Liotrix—hypothyroidism	0.00243	0.00655	CcSEcCtD
Bromocriptine—ADRB1—cardiovascular system—hypothyroidism	0.00242	0.0148	CbGeAlD
Bromocriptine—Nervousness—Liotrix—hypothyroidism	0.00241	0.00649	CcSEcCtD
Bromocriptine—Fatigue—Levothyroxine—hypothyroidism	0.00238	0.00639	CcSEcCtD
Bromocriptine—Fatigue—Dextrothyroxine—hypothyroidism	0.00238	0.00639	CcSEcCtD
Bromocriptine—Vision blurred—Liotrix—hypothyroidism	0.00234	0.0063	CcSEcCtD
Bromocriptine—HTR2B—cardiovascular system—hypothyroidism	0.00232	0.0142	CbGeAlD
Bromocriptine—Agitation—Liotrix—hypothyroidism	0.00228	0.00614	CcSEcCtD
Bromocriptine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00227	0.00611	CcSEcCtD
Bromocriptine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00227	0.00611	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00225	0.00606	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00225	0.00606	CcSEcCtD
Bromocriptine—Syncope—Liotrix—hypothyroidism	0.00223	0.00599	CcSEcCtD
Bromocriptine—Urticaria—Dextrothyroxine—hypothyroidism	0.00219	0.00589	CcSEcCtD
Bromocriptine—Urticaria—Levothyroxine—hypothyroidism	0.00219	0.00589	CcSEcCtD
Bromocriptine—Loss of consciousness—Liotrix—hypothyroidism	0.00218	0.00588	CcSEcCtD
Bromocriptine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00218	0.00586	CcSEcCtD
Bromocriptine—Body temperature increased—Levothyroxine—hypothyroidism	0.00218	0.00586	CcSEcCtD
Bromocriptine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00218	0.00586	CcSEcCtD
Bromocriptine—Abdominal pain—Levothyroxine—hypothyroidism	0.00218	0.00586	CcSEcCtD
Bromocriptine—Convulsion—Liotrix—hypothyroidism	0.00215	0.00579	CcSEcCtD
Bromocriptine—Hypertension—Liotrix—hypothyroidism	0.00214	0.00577	CcSEcCtD
Bromocriptine—Anxiety—Liotrix—hypothyroidism	0.00211	0.00567	CcSEcCtD
Bromocriptine—HTR7—heart—hypothyroidism	0.0021	0.0129	CbGeAlD
Bromocriptine—HTR1A—cardiovascular system—hypothyroidism	0.00208	0.0127	CbGeAlD
Bromocriptine—Confusional state—Liotrix—hypothyroidism	0.00204	0.0055	CcSEcCtD
Bromocriptine—Oedema—Liotrix—hypothyroidism	0.00203	0.00546	CcSEcCtD
Bromocriptine—ADRA1A—heart—hypothyroidism	0.00203	0.0124	CbGeAlD
Bromocriptine—Infection—Liotrix—hypothyroidism	0.00201	0.00542	CcSEcCtD
Bromocriptine—ADRA2C—adrenal cortex—hypothyroidism	0.002	0.0122	CbGeAlD
Bromocriptine—Shock—Liotrix—hypothyroidism	0.00199	0.00537	CcSEcCtD
Bromocriptine—HTR7—cardiovascular system—hypothyroidism	0.00198	0.0122	CbGeAlD
Bromocriptine—Tachycardia—Liotrix—hypothyroidism	0.00198	0.00532	CcSEcCtD
Bromocriptine—Asthenia—Levothyroxine—hypothyroidism	0.00198	0.00532	CcSEcCtD
Bromocriptine—Asthenia—Dextrothyroxine—hypothyroidism	0.00198	0.00532	CcSEcCtD
Bromocriptine—Anorexia—Liotrix—hypothyroidism	0.00193	0.0052	CcSEcCtD
Bromocriptine—ADRA2C—heart—hypothyroidism	0.00193	0.0118	CbGeAlD
Bromocriptine—ADRA1A—cardiovascular system—hypothyroidism	0.00191	0.0117	CbGeAlD
Bromocriptine—Hypotension—Liotrix—hypothyroidism	0.00189	0.0051	CcSEcCtD
Bromocriptine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00189	0.00507	CcSEcCtD
Bromocriptine—Diarrhoea—Levothyroxine—hypothyroidism	0.00189	0.00507	CcSEcCtD
Bromocriptine—Insomnia—Liotrix—hypothyroidism	0.00183	0.00493	CcSEcCtD
Bromocriptine—HTR2B—adrenal gland—hypothyroidism	0.00183	0.0112	CbGeAlD
Bromocriptine—HTR2B—blood—hypothyroidism	0.00183	0.0112	CbGeAlD
Bromocriptine—Paraesthesia—Liotrix—hypothyroidism	0.00182	0.0049	CcSEcCtD
Bromocriptine—Dyspnoea—Liotrix—hypothyroidism	0.00181	0.00486	CcSEcCtD
Bromocriptine—HTR7—gonad—hypothyroidism	0.0018	0.011	CbGeAlD
Bromocriptine—HTR2B—thyroid gland—hypothyroidism	0.00177	0.0108	CbGeAlD
Bromocriptine—Decreased appetite—Liotrix—hypothyroidism	0.00176	0.00474	CcSEcCtD
Bromocriptine—Vomiting—Dextrothyroxine—hypothyroidism	0.00175	0.00472	CcSEcCtD
Bromocriptine—Vomiting—Levothyroxine—hypothyroidism	0.00175	0.00472	CcSEcCtD
Bromocriptine—Fatigue—Liotrix—hypothyroidism	0.00175	0.0047	CcSEcCtD
Bromocriptine—Rash—Dextrothyroxine—hypothyroidism	0.00174	0.00468	CcSEcCtD
Bromocriptine—Rash—Levothyroxine—hypothyroidism	0.00174	0.00468	CcSEcCtD
Bromocriptine—Dermatitis—Levothyroxine—hypothyroidism	0.00174	0.00467	CcSEcCtD
Bromocriptine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00174	0.00467	CcSEcCtD
Bromocriptine—Constipation—Liotrix—hypothyroidism	0.00173	0.00467	CcSEcCtD
Bromocriptine—Headache—Levothyroxine—hypothyroidism	0.00173	0.00465	CcSEcCtD
Bromocriptine—Headache—Dextrothyroxine—hypothyroidism	0.00173	0.00465	CcSEcCtD
Bromocriptine—Feeling abnormal—Liotrix—hypothyroidism	0.00167	0.0045	CcSEcCtD
Bromocriptine—DRD2—pituitary gland—hypothyroidism	0.00166	0.0102	CbGeAlD
Bromocriptine—Gastrointestinal pain—Liotrix—hypothyroidism	0.00166	0.00446	CcSEcCtD
Bromocriptine—HTR1A—adrenal gland—hypothyroidism	0.00164	0.0101	CbGeAlD
Bromocriptine—Nausea—Dextrothyroxine—hypothyroidism	0.00164	0.00441	CcSEcCtD
Bromocriptine—Nausea—Levothyroxine—hypothyroidism	0.00164	0.00441	CcSEcCtD
Bromocriptine—ADRA2C—pituitary gland—hypothyroidism	0.00161	0.0099	CbGeAlD
Bromocriptine—Urticaria—Liotrix—hypothyroidism	0.00161	0.00433	CcSEcCtD
Bromocriptine—Body temperature increased—Liotrix—hypothyroidism	0.0016	0.00431	CcSEcCtD
Bromocriptine—Abdominal pain—Liotrix—hypothyroidism	0.0016	0.00431	CcSEcCtD
Bromocriptine—HTR7—adrenal gland—hypothyroidism	0.00157	0.00962	CbGeAlD
Bromocriptine—HTR7—blood—hypothyroidism	0.00157	0.00962	CbGeAlD
Bromocriptine—ADRA2A—heart—hypothyroidism	0.00154	0.00945	CbGeAlD
Bromocriptine—ADRA1A—adrenal gland—hypothyroidism	0.00151	0.00928	CbGeAlD
Bromocriptine—ADRA1A—blood—hypothyroidism	0.00151	0.00927	CbGeAlD
Bromocriptine—Asthenia—Liotrix—hypothyroidism	0.00145	0.00391	CcSEcCtD
Bromocriptine—ADRA2C—adrenal gland—hypothyroidism	0.00144	0.00884	CbGeAlD
Bromocriptine—ADRA2C—blood—hypothyroidism	0.00144	0.00884	CbGeAlD
Bromocriptine—Diarrhoea—Liotrix—hypothyroidism	0.00139	0.00373	CcSEcCtD
Bromocriptine—ADRA2C—female gonad—hypothyroidism	0.00134	0.00824	CbGeAlD
Bromocriptine—Dizziness—Liotrix—hypothyroidism	0.00134	0.00361	CcSEcCtD
Bromocriptine—ADRA2A—gonad—hypothyroidism	0.00132	0.00809	CbGeAlD
Bromocriptine—HTR2A—heart—hypothyroidism	0.00131	0.00804	CbGeAlD
Bromocriptine—HTR7—testis—hypothyroidism	0.0013	0.00795	CbGeAlD
Bromocriptine—Vomiting—Liotrix—hypothyroidism	0.00129	0.00347	CcSEcCtD
Bromocriptine—ADRA2A—pituitary gland—hypothyroidism	0.00129	0.0079	CbGeAlD
Bromocriptine—Rash—Liotrix—hypothyroidism	0.00128	0.00344	CcSEcCtD
Bromocriptine—Dermatitis—Liotrix—hypothyroidism	0.00128	0.00344	CcSEcCtD
Bromocriptine—Headache—Liotrix—hypothyroidism	0.00127	0.00342	CcSEcCtD
Bromocriptine—HTR1A—cerebellum—hypothyroidism	0.00125	0.00769	CbGeAlD
Bromocriptine—CYP1A2—blood—hypothyroidism	0.00125	0.00767	CbGeAlD
Bromocriptine—HTR2A—cardiovascular system—hypothyroidism	0.00124	0.00758	CbGeAlD
Bromocriptine—DRD2—testis—hypothyroidism	0.00123	0.00752	CbGeAlD
Bromocriptine—HTR7—liver—hypothyroidism	0.00123	0.00752	CbGeAlD
Bromocriptine—CYP1A2—thyroid gland—hypothyroidism	0.00121	0.0074	CbGeAlD
Bromocriptine—Nausea—Liotrix—hypothyroidism	0.0012	0.00324	CcSEcCtD
Bromocriptine—HTR7—cerebellum—hypothyroidism	0.0012	0.00735	CbGeAlD
Bromocriptine—ADRA2C—testis—hypothyroidism	0.00119	0.00731	CbGeAlD
Bromocriptine—ADRA1A—liver—hypothyroidism	0.00118	0.00725	CbGeAlD
Bromocriptine—ADRA1A—cerebellum—hypothyroidism	0.00116	0.00709	CbGeAlD
Bromocriptine—ADRA2A—adrenal gland—hypothyroidism	0.00115	0.00705	CbGeAlD
Bromocriptine—ADRA2A—blood—hypothyroidism	0.00115	0.00705	CbGeAlD
Bromocriptine—DRD2—cerebellum—hypothyroidism	0.00113	0.00694	CbGeAlD
Bromocriptine—ADRA2C—liver—hypothyroidism	0.00113	0.00691	CbGeAlD
Bromocriptine—HTR2A—gonad—hypothyroidism	0.00112	0.00688	CbGeAlD
Bromocriptine—ADRA2A—thyroid gland—hypothyroidism	0.00111	0.00681	CbGeAlD
Bromocriptine—ADRA2C—cerebellum—hypothyroidism	0.0011	0.00675	CbGeAlD
Bromocriptine—HTR2A—pituitary gland—hypothyroidism	0.00109	0.00671	CbGeAlD
Bromocriptine—ADRA2A—female gonad—hypothyroidism	0.00107	0.00658	CbGeAlD
Bromocriptine—HTR2A—adrenal gland—hypothyroidism	0.000978	0.006	CbGeAlD
Bromocriptine—CYP1A2—liver—hypothyroidism	0.000978	0.006	CbGeAlD
Bromocriptine—HTR2A—blood—hypothyroidism	0.000978	0.006	CbGeAlD
Bromocriptine—ADRA2A—testis—hypothyroidism	0.000951	0.00583	CbGeAlD
Bromocriptine—CYP3A4—blood—hypothyroidism	0.000905	0.00555	CbGeAlD
Bromocriptine—ABCB1—adrenal cortex—hypothyroidism	0.000888	0.00544	CbGeAlD
Bromocriptine—ADRA2A—cerebellum—hypothyroidism	0.000879	0.00539	CbGeAlD
Bromocriptine—ABCB1—heart—hypothyroidism	0.000859	0.00527	CbGeAlD
Bromocriptine—ABCB1—cardiovascular system—hypothyroidism	0.00081	0.00497	CbGeAlD
Bromocriptine—HTR2A—testis—hypothyroidism	0.000809	0.00496	CbGeAlD
Bromocriptine—HTR2A—liver—hypothyroidism	0.000765	0.00469	CbGeAlD
Bromocriptine—HTR2A—cerebellum—hypothyroidism	0.000747	0.00458	CbGeAlD
Bromocriptine—ABCB1—gonad—hypothyroidism	0.000736	0.00451	CbGeAlD
Bromocriptine—ABCB1—pituitary gland—hypothyroidism	0.000718	0.0044	CbGeAlD
Bromocriptine—CYP3A4—liver—hypothyroidism	0.000708	0.00434	CbGeAlD
Bromocriptine—ABCB1—adrenal gland—hypothyroidism	0.000641	0.00393	CbGeAlD
Bromocriptine—ABCB1—blood—hypothyroidism	0.000641	0.00393	CbGeAlD
Bromocriptine—ABCB1—thyroid gland—hypothyroidism	0.000619	0.00379	CbGeAlD
Bromocriptine—ABCB1—female gonad—hypothyroidism	0.000598	0.00366	CbGeAlD
Bromocriptine—ABCB1—testis—hypothyroidism	0.00053	0.00325	CbGeAlD
Bromocriptine—ABCB1—liver—hypothyroidism	0.000501	0.00307	CbGeAlD
Bromocriptine—ABCB1—cerebellum—hypothyroidism	0.00049	0.003	CbGeAlD
Bromocriptine—DRD2—GPCR ligand binding—POMC—hypothyroidism	6.74e-05	0.000617	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TRH—hypothyroidism	6.67e-05	0.00061	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CLTC—hypothyroidism	6.66e-05	0.00061	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—TPO—hypothyroidism	6.66e-05	0.000609	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TRH—hypothyroidism	6.63e-05	0.000607	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—POMC—hypothyroidism	6.63e-05	0.000607	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	6.56e-05	0.0006	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	6.53e-05	0.000598	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	6.53e-05	0.000597	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	6.53e-05	0.000597	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	6.5e-05	0.000594	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	6.49e-05	0.000594	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	6.45e-05	0.00059	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TRH—hypothyroidism	6.45e-05	0.00059	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—VAV3—hypothyroidism	6.43e-05	0.000589	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—IYD—hypothyroidism	6.43e-05	0.000588	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—IGF1—hypothyroidism	6.39e-05	0.000585	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	6.37e-05	0.000583	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—VAV3—hypothyroidism	6.36e-05	0.000582	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TRH—hypothyroidism	6.35e-05	0.000581	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	6.32e-05	0.000578	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	6.22e-05	0.000569	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TSHB—hypothyroidism	6.21e-05	0.000568	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TSHR—hypothyroidism	6.21e-05	0.000568	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AVP—hypothyroidism	6.2e-05	0.000567	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.17e-05	0.000565	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.17e-05	0.000565	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SH2B3—hypothyroidism	6.16e-05	0.000564	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	6.16e-05	0.000563	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	6.16e-05	0.000563	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	6.15e-05	0.000563	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	6.14e-05	0.000562	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AVP—hypothyroidism	6.13e-05	0.000561	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	6.13e-05	0.000561	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	6.12e-05	0.00056	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SH2B3—hypothyroidism	6.08e-05	0.000556	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SH2B3—hypothyroidism	6.08e-05	0.000556	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	6.06e-05	0.000555	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	6.03e-05	0.000552	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	5.95e-05	0.000545	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	5.95e-05	0.000544	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TSHB—hypothyroidism	5.94e-05	0.000544	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TSHR—hypothyroidism	5.94e-05	0.000544	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AVP—hypothyroidism	5.93e-05	0.000542	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TSHB—hypothyroidism	5.91e-05	0.000541	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TSHR—hypothyroidism	5.91e-05	0.000541	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AVP—hypothyroidism	5.9e-05	0.00054	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—POMC—hypothyroidism	5.86e-05	0.000536	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	5.86e-05	0.000536	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—POMC—hypothyroidism	5.85e-05	0.000536	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	5.85e-05	0.000536	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TRH—hypothyroidism	5.85e-05	0.000536	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	5.82e-05	0.000532	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TRH—hypothyroidism	5.76e-05	0.000527	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	5.75e-05	0.000526	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	5.75e-05	0.000526	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	5.74e-05	0.000525	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	5.73e-05	0.000524	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	5.73e-05	0.000524	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—POMC—hypothyroidism	5.7e-05	0.000521	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	5.66e-05	0.000518	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	5.66e-05	0.000518	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	5.65e-05	0.000517	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	5.64e-05	0.000516	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TRH—hypothyroidism	5.64e-05	0.000516	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—POMC—hypothyroidism	5.6e-05	0.000513	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—TSHB—hypothyroidism	5.59e-05	0.000511	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SH2B3—hypothyroidism	5.54e-05	0.000507	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	5.52e-05	0.000505	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	5.49e-05	0.000502	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.47e-05	0.0005	CbGpPWpGaD
Bromocriptine—CYP3A4—Biological oxidations—POMC—hypothyroidism	5.45e-05	0.000499	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	5.4e-05	0.000494	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	5.35e-05	0.000489	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	5.33e-05	0.000487	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—POMC—hypothyroidism	5.32e-05	0.000487	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—POMC—hypothyroidism	5.32e-05	0.000486	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	5.32e-05	0.000486	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PRL—hypothyroidism	5.31e-05	0.000486	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PRL—hypothyroidism	5.3e-05	0.000485	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	5.3e-05	0.000485	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—POMC—hypothyroidism	5.28e-05	0.000483	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	5.27e-05	0.000482	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PRL—hypothyroidism	5.27e-05	0.000482	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TRH—hypothyroidism	5.24e-05	0.000479	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TSHB—hypothyroidism	5.22e-05	0.000477	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TSHR—hypothyroidism	5.22e-05	0.000477	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	5.21e-05	0.000476	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AVP—hypothyroidism	5.21e-05	0.000476	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—IGF1—hypothyroidism	5.19e-05	0.000475	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—POMC—hypothyroidism	5.17e-05	0.000473	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PRL—hypothyroidism	5.16e-05	0.000472	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—SLC5A5—hypothyroidism	5.15e-05	0.000471	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TPO—hypothyroidism	5.14e-05	0.00047	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TSHB—hypothyroidism	5.13e-05	0.00047	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TSHR—hypothyroidism	5.13e-05	0.00047	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	5.13e-05	0.000469	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	5.13e-05	0.000469	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AVP—hypothyroidism	5.12e-05	0.000469	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—POMC—hypothyroidism	5.09e-05	0.000466	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PRL—hypothyroidism	5.08e-05	0.000464	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—POMC—hypothyroidism	5.05e-05	0.000462	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	5.04e-05	0.000461	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	5.03e-05	0.00046	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	5.03e-05	0.00046	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	5.02e-05	0.000459	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	4.98e-05	0.000455	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—POMC—hypothyroidism	4.98e-05	0.000455	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—POMC—hypothyroidism	4.98e-05	0.000455	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—VAV3—hypothyroidism	4.91e-05	0.000449	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—VAV3—hypothyroidism	4.91e-05	0.000449	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—VAV3—hypothyroidism	4.87e-05	0.000446	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.86e-05	0.000445	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—POMC—hypothyroidism	4.86e-05	0.000445	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PRL—hypothyroidism	4.85e-05	0.000443	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	4.84e-05	0.000443	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—VAV3—hypothyroidism	4.77e-05	0.000437	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AVP—hypothyroidism	4.73e-05	0.000433	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AVP—hypothyroidism	4.73e-05	0.000432	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—VAV3—hypothyroidism	4.7e-05	0.00043	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AVP—hypothyroidism	4.7e-05	0.00043	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	4.67e-05	0.000427	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	4.67e-05	0.000427	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	4.66e-05	0.000426	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	4.65e-05	0.000425	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AVP—hypothyroidism	4.6e-05	0.000421	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—POMC—hypothyroidism	4.58e-05	0.000419	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	4.58e-05	0.000419	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PRL—hypothyroidism	4.57e-05	0.000418	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—POMC—hypothyroidism	4.54e-05	0.000415	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AVP—hypothyroidism	4.52e-05	0.000414	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—POMC—hypothyroidism	4.52e-05	0.000414	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—POMC—hypothyroidism	4.52e-05	0.000414	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PRL—hypothyroidism	4.51e-05	0.000413	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PRL—hypothyroidism	4.51e-05	0.000413	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	4.49e-05	0.000411	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—VAV3—hypothyroidism	4.48e-05	0.00041	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	4.48e-05	0.00041	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	4.34e-05	0.000397	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AVP—hypothyroidism	4.32e-05	0.000395	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	4.32e-05	0.000395	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VAV3—hypothyroidism	4.23e-05	0.000387	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	4.2e-05	0.000384	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—SLC5A5—hypothyroidism	4.18e-05	0.000383	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VAV3—hypothyroidism	4.17e-05	0.000382	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VAV3—hypothyroidism	4.17e-05	0.000382	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	4.16e-05	0.000381	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	4.13e-05	0.000378	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—POMC—hypothyroidism	4.12e-05	0.000377	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PRL—hypothyroidism	4.11e-05	0.000376	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	4.08e-05	0.000373	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—POMC—hypothyroidism	4.07e-05	0.000373	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AVP—hypothyroidism	4.07e-05	0.000373	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PRL—hypothyroidism	4.07e-05	0.000372	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AVP—hypothyroidism	4.02e-05	0.000368	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AVP—hypothyroidism	4.02e-05	0.000368	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—POMC—hypothyroidism	3.94e-05	0.00036	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PRL—hypothyroidism	3.93e-05	0.00036	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—POMC—hypothyroidism	3.92e-05	0.000359	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IGF1—hypothyroidism	3.92e-05	0.000358	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PRL—hypothyroidism	3.91e-05	0.000358	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—TSHB—hypothyroidism	3.86e-05	0.000353	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	3.81e-05	0.000349	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	3.81e-05	0.000349	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PRL—hypothyroidism	3.8e-05	0.000348	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VAV3—hypothyroidism	3.8e-05	0.000348	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	3.77e-05	0.000345	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	3.75e-05	0.000343	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	3.75e-05	0.000343	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PRL—hypothyroidism	3.74e-05	0.000342	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	3.67e-05	0.000336	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AVP—hypothyroidism	3.66e-05	0.000335	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VAV3—hypothyroidism	3.64e-05	0.000333	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AVP—hypothyroidism	3.63e-05	0.000332	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VAV3—hypothyroidism	3.62e-05	0.000331	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	3.52e-05	0.000322	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AVP—hypothyroidism	3.5e-05	0.00032	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AVP—hypothyroidism	3.48e-05	0.000319	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	3.46e-05	0.000317	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—POMC—hypothyroidism	3.46e-05	0.000316	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PRL—hypothyroidism	3.45e-05	0.000316	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	3.44e-05	0.000315	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	3.41e-05	0.000312	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—POMC—hypothyroidism	3.4e-05	0.000311	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PRL—hypothyroidism	3.39e-05	0.000311	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AVP—hypothyroidism	3.39e-05	0.00031	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AVP—hypothyroidism	3.34e-05	0.000305	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	3.33e-05	0.000305	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PRL—hypothyroidism	3.32e-05	0.000304	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VAV3—hypothyroidism	3.19e-05	0.000292	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—POMC—hypothyroidism	3.14e-05	0.000288	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—POMC—hypothyroidism	3.14e-05	0.000287	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VAV3—hypothyroidism	3.14e-05	0.000287	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—POMC—hypothyroidism	3.12e-05	0.000285	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	3.1e-05	0.000283	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PRL—hypothyroidism	3.09e-05	0.000283	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—TSHB—hypothyroidism	3.08e-05	0.000282	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	3.08e-05	0.000281	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AVP—hypothyroidism	3.08e-05	0.000281	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—POMC—hypothyroidism	3.06e-05	0.00028	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AVP—hypothyroidism	3.03e-05	0.000277	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IGF1—hypothyroidism	3.02e-05	0.000277	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IGF1—hypothyroidism	3.02e-05	0.000276	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—POMC—hypothyroidism	3.01e-05	0.000275	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IGF1—hypothyroidism	3e-05	0.000275	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AVP—hypothyroidism	2.96e-05	0.000271	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IGF1—hypothyroidism	2.94e-05	0.000269	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IGF1—hypothyroidism	2.89e-05	0.000265	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.89e-05	0.000265	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—POMC—hypothyroidism	2.87e-05	0.000263	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	2.86e-05	0.000261	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IGF1—hypothyroidism	2.76e-05	0.000253	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AVP—hypothyroidism	2.75e-05	0.000252	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	2.75e-05	0.000251	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.71e-05	0.000248	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—POMC—hypothyroidism	2.71e-05	0.000248	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—POMC—hypothyroidism	2.69e-05	0.000246	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—POMC—hypothyroidism	2.67e-05	0.000244	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—POMC—hypothyroidism	2.67e-05	0.000244	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IGF1—hypothyroidism	2.6e-05	0.000238	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IGF1—hypothyroidism	2.57e-05	0.000235	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IGF1—hypothyroidism	2.57e-05	0.000235	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—POMC—hypothyroidism	2.43e-05	0.000223	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—POMC—hypothyroidism	2.41e-05	0.000221	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TSHB—hypothyroidism	2.38e-05	0.000218	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IGF1—hypothyroidism	2.34e-05	0.000214	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—POMC—hypothyroidism	2.33e-05	0.000213	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	2.32e-05	0.000212	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—POMC—hypothyroidism	2.32e-05	0.000212	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—SLC5A5—hypothyroidism	2.31e-05	0.000211	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—POMC—hypothyroidism	2.25e-05	0.000206	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IGF1—hypothyroidism	2.24e-05	0.000205	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IGF1—hypothyroidism	2.23e-05	0.000204	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—POMC—hypothyroidism	2.22e-05	0.000203	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—POMC—hypothyroidism	2.19e-05	0.0002	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	2.17e-05	0.000198	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	2.13e-05	0.000195	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.12e-05	0.000194	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—POMC—hypothyroidism	2.04e-05	0.000187	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—POMC—hypothyroidism	2.01e-05	0.000184	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—POMC—hypothyroidism	1.97e-05	0.00018	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IGF1—hypothyroidism	1.97e-05	0.00018	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IGF1—hypothyroidism	1.93e-05	0.000177	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	1.89e-05	0.000173	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—POMC—hypothyroidism	1.83e-05	0.000167	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.78e-05	0.000163	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	1.76e-05	0.000161	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—POMC—hypothyroidism	1.51e-05	0.000138	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—POMC—hypothyroidism	1.21e-05	0.00011	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—POMC—hypothyroidism	9.32e-06	8.53e-05	CbGpPWpGaD
